GERD (Gastroesophageal Reflux Disease): Symptoms, Treatment and Lifestyle Changes

What Is Reflux (GERD)?

Hello, I am Dr. Emre Geçer. Gastroesophageal reflux disease (GERD) is a chronic illness that develops when stomach acid — and sometimes bile — flows back into the esophagus (food pipe), causing bothersome symptoms and/or mucosal damage.

In fact, everyone experiences reflux from time to time — brief regurgitation of stomach contents after large meals is physiological. However, when it occurs frequently, persists for a long time, and leads to symptoms or complications, it is classified as a disease.

GERD is highly prevalent in Western societies; 20–30% of adults experience reflux symptoms at least once a week. It is a chronic condition and, if left untreated, can lead to serious complications such as esophagitis, stricture, Barrett's esophagus, and rarely esophageal cancer.

Pathophysiology: Why Does Reflux Occur?

Normally, the lower esophageal sphincter (LES) — located at the junction of the esophagus and the stomach — works like a one-way valve: it opens during swallowing to allow food into the stomach and remains closed at other times to prevent gastric contents from refluxing. GERD develops when this protective mechanism breaks down.

Mechanisms Leading to GERD

• Transient lower esophageal sphincter relaxations (tLESRs): The most common mechanism of GERD. The LES relaxes spontaneously and inappropriately outside of swallowing, allowing reflux.
• Decreased LES pressure: Chronically weak LES tone sets the stage for ongoing reflux.
• Hiatal hernia: A hiatal hernia weakens the antireflux barrier by separating the LES from the diaphragmatic crura; it also facilitates formation of an acid pocket.
• Insufficient esophageal clearance: Weakened esophageal peristalsis slows clearance of refluxed acid.
• Reduced mucosal resistance: Inadequate defense mechanisms of the esophageal mucosa against acid and pepsin.
• Delayed gastric emptying: Gastroparesis or functional disorders increase gastric content volume and raise reflux pressure.

Symptoms

Typical (Esophageal) Symptoms

• Heartburn: GERD's most characteristic symptom. A burning sensation rising behind the sternum (breastbone) from the epigastrium toward the neck. It worsens after meals, when lying down, and when bending forward.
• Regurgitation: The effortless return of gastric contents (acidic fluid or partially digested food) into the mouth. Unlike heartburn, it is a mechanical backflow.

Atypical (Extraesophageal) Symptoms

GERD can affect many organs and systems beyond the esophagus. These symptoms often delay diagnosis:

• Chronic cough: A persistent cough — especially at night and after meals — without an identified cause; GERD is one of the three most common causes of chronic cough.
• Laryngitis and hoarseness: Vocal cord damage from laryngopharyngeal reflux (LPR).
• Asthma-like symptoms: Wheezing and shortness of breath — reflux can worsen existing asthma or trigger asthma-like symptoms.
• Dental erosion: Erosion of tooth enamel by gastric acid, particularly on the inner surfaces of posterior teeth.
• Non-cardiac chest pain: After cardiac causes are excluded, GERD is the most common cause of non-cardiac chest pain.
• Globus sensation: A feeling of a lump or something stuck in the throat.
• Dysphagia: Difficulty swallowing (suggests development of a complication).
• Otalgia (ear pain): Via referred pain pathways.

Alarm Symptoms (Red Flags)

The following symptoms suggest a more serious pathology (stricture, ulcer, cancer) and require urgent endoscopic evaluation:

• Dysphagia (especially progressive — first solid, then liquid foods)
• Odynophagia (painful swallowing)
• Unintentional weight loss
• Gastrointestinal bleeding (hematemesis, melena, iron-deficiency anemia)
• Recurrent vomiting
• New-onset symptoms in patients over 55
• Family history of esophageal or gastric cancer

Diagnostic Methods

1. Empiric PPI Therapy (PPI Test)

In young patients (<55 years) with typical reflux symptoms and no alarm features, the initial approach is usually an 8-week diagnostic trial of PPI therapy. If symptoms improve significantly with the PPI, the diagnosis of GERD is supported clinically. This approach avoids unnecessary endoscopies.

2. Upper Gastrointestinal Endoscopy

Indicated in the presence of alarm symptoms, PPI non-response, or for Barrett's surveillance. Endoscopy allows the clinician to:

• Grade the severity of esophagitis (Los Angeles classification: A–D)
• Evaluate for stricture, Barrett's esophagus, and malignancy
• Obtain biopsies

Important note: Endoscopy is normal in approximately 50–70% of GERD patients (non-erosive reflux disease — NERD).

3. 24-Hour pH Monitoring and Impedance

This is the gold standard for diagnosing GERD. Esophageal acid exposure is measured over 24–48 hours using a thin catheter or a wireless capsule (Bravo).

• A DeMeester score >14.7 is considered pathological reflux.
• Impedance also detects non-acidic (weakly acidic) reflux episodes.
• Critical for evaluating symptoms that persist despite PPI therapy.
• Required for diagnostic confirmation before surgery.

4. Esophageal Manometry

Assesses LES pressure and esophageal motility. It is not used to diagnose GERD itself but for preoperative evaluation and to exclude motility disorders such as achalasia.

Treatment

1. Lifestyle Changes

Lifestyle modification is the fundamental treatment component recommended for all GERD patients. Combined with medication, it increases overall efficacy.

Diet and Nutrition

• Avoid trigger foods: Fatty meals, chocolate, mint, caffeinated drinks, alcohol, citrus fruits, tomato sauce, onion, garlic, spicy foods, carbonated beverages.
• Small portions, frequent meals: Reduces gastric distention.
• Eat slowly: Chew each bite thoroughly.
• Last meal: Finish eating at least 3 hours before bedtime.
• Fluid intake: Avoid excessive fluid intake during meals.

Positional Measures

• Elevate the head of the bed: Place a 15–20 cm wedge or block under the head of the bed. Stacking pillows is not sufficient — the upper half of the body needs to be inclined.
• Lie on the left side: Because of stomach anatomy, lying on the left side keeps the gastroesophageal junction above the gastric acid pool and reduces reflux.
• Do not lie down after eating: Stay upright for at least 2–3 hours.

Other Lifestyle Changes

• Weight loss: Obesity is GERD's strongest modifiable risk factor. Each 1-unit increase in BMI raises GERD risk by 10%.
• Smoking cessation: Nicotine lowers LES pressure, reduces saliva production, and impairs esophageal clearance.
• Avoid tight clothing: Belts and garments that increase abdominal pressure.
• Stress management: Stress can heighten esophageal hypersensitivity.

2. Medical Treatment

Proton Pump Inhibitors (PPIs)

PPIs are the gold standard of GERD medical therapy. They irreversibly inhibit the H+/K+ ATPase pump in gastric parietal cells, reducing acid production by up to 90%.

• Active agents: Omeprazole, lansoprazole, pantoprazole, esomeprazole, rabeprazole, dexlansoprazole.
• Use: Once daily, 30 minutes before breakfast, on an empty stomach (to inhibit the proton pumps before the acid-secretion cycle starts).
• Treatment duration: Initial course 8 weeks; if there is a response, step down to the lowest effective dose or transition to on-demand use.
• Effect: Symptom improvement 80–90%; esophagitis healing 85–95%.

Considerations for Long-Term PPI Use

PPIs are generally safe drugs, but the potential risks reported with long-term use should be considered carefully:

• Magnesium deficiency: Hypomagnesemia can develop with long-term use.
• Vitamin B12 deficiency: Acid suppression can reduce B12 absorption.
• Calcium absorption and fracture risk: Debated; long-term use may slightly increase the risk of hip fracture.
• Clostridium difficile infection: Risk may increase as the gastric acid barrier is reduced.
• Rebound acid hypersecretion: Sudden withdrawal of a PPI can transiently worsen symptoms; gradual dose tapering is recommended.
• Acute interstitial nephritis: Rare.

These risks should not prevent PPI use in patients with a true indication; however, prescribing without an indication or for unnecessarily long durations should be avoided.

H2 Receptor Antagonists (H2RAs)

• Famotidine: Reduces acid secretion by blocking histamine H2 receptors; weaker than PPIs.
• Can be used in mild GERD or added to a PPI for nighttime reflux.
• Tolerance (reduced efficacy) can become a problem with long-term use.

Antacids and Alginates

• Antacids: Provide quick, transient symptom relief; their role in long-term treatment is limited.
• Alginate-based products: Form a mechanical barrier on top of the stomach contents; effective during the postprandial reflux period.

3. Surgical Treatment

Surgery is considered in patients whose symptoms remain uncontrolled despite maximal medical therapy or in those who do not wish to remain on long-term medication.

Laparoscopic Nissen Fundoplication

A mechanical antireflux barrier created by wrapping the gastric fundus 360 degrees around the lower esophagus. The long-term success rate is high (85–90%).

LINX Magnetic Sphincter Augmentation

A ring of magnetic beads placed around the LES. It opens during swallowing by overcoming the magnetic force and supports LES pressure at rest. Less invasive than fundoplication and carries a lower risk of gas-bloat syndrome.

Barrett's Esophagus: Cancer Risk

Barrett's esophagus is the replacement of the normal squamous epithelium of the lower esophagus with intestinal metaplasia due to chronic GERD. It is found in approximately 10–15% of GERD patients.

• Barrett's esophagus is the most important risk factor for esophageal adenocarcinoma.
• Risk of progression from Barrett's to cancer: 0.5% per year (when no dysplasia is present).
• The risk increases with low-grade dysplasia; with high-grade dysplasia it can rise to up to 6% per year.

Screening recommendations: Endoscopic screening should be considered in men over 50 with chronic GERD symptoms (>5 years) and additional risk factors (obesity, smoking, family history of Barrett's or esophageal cancer). If Barrett's is detected, regular surveillance endoscopy is performed according to the degree of dysplasia, and endoscopic therapy (radiofrequency ablation, endoscopic mucosal resection) is applied when indicated.

GERD and Daily Life: Practical Tips

• Keep a symptom diary: note which foods and activities trigger reflux.
• Eat sitting upright, in a calm environment, without rushing.
• Chewing gum between meals increases saliva production and supports esophageal clearance.
• Drink plenty of water, but avoid excessive fluid intake during meals.
• Exercise is beneficial, but avoid intense physical activity right after eating; movements that increase intra-abdominal pressure in particular (weightlifting, sit-ups) can trigger reflux.

When Should You See a Doctor?

• Reflux complaints more than twice a week
• Symptoms not controlled by antacids
• Complaints persisting despite 8 weeks of PPI therapy
• Presence of any alarm symptom (dysphagia, weight loss, bleeding)
• Chronic reflux for more than 5 years (for Barrett's screening)
• Chronic cough or hoarseness linked to reflux
• Sleep disturbance due to nighttime reflux

Conclusion

Reflux (GERD) is an extremely common and chronic — yet effectively manageable — disease. Lifestyle changes form the foundation of treatment and enhance the efficacy of medications. PPIs are the gold standard of GERD's medical therapy. Endoscopic evaluation must not be neglected when alarm symptoms are present, and Barrett's esophagus screening should be considered in long-standing GERD patients. Surgery offers an effective alternative to medical therapy in appropriate patients. The most important message: do not accept reflux as a normal part of life, and do not ignore serious symptoms.

Wishing you healthy days.
Dr. Emre Geçer

References

• Harrison's Principles of Internal Medicine, 22nd Edition — Chapter: Diseases of the Esophagus
• Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 11th Edition
• Katz PO, et al. ACG Clinical Guideline: Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease. Am J Gastroenterol. 2022
• Shaheen NJ, et al. ACG Clinical Guideline: Diagnosis, Surveillance, and Therapy of Barrett's Esophagus. Am J Gastroenterol. 2016